AWA
WST icon

Arete Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Arete Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-532
Closed -$218K – 569
2022
Q1 		$218K Buy
532
+38
+8% +$14.9K 0.02% 457
2021
Q4 		$222K Buy
+494
New +$213K 0.02% 450

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Arete Wealth Advisors's WST Position: Q2 2022 in Review

Arete Wealth Advisors sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 532 shares — an estimated $218K sold.

Arete Wealth Advisors first reported a position in WST in Q4 2021 and held it in 2 quarters. The position peaked at $222K in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Arete Wealth Advisors reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Arete Wealth Advisors sold 532 West Pharmaceutical shares in Q2 2022, an estimated $218K.
  • Arete Wealth Advisors first reported a position in West Pharmaceutical in Q4 2021 and held it in 2 quarters.
  • Arete Wealth Advisors's West Pharmaceutical position peaked at $222K in Q4 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Arete Wealth Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.